» Articles » PMID: 38072172

Mechanical Loading of Joint Modulates T Cells in Lymph Nodes to Regulate Osteoarthritis

Overview
Date 2023 Dec 10
PMID 38072172
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The crosstalk of joint pathology with local lymph nodes in osteoarthritis (OA) is poorly understood. We characterized the change in T cells in lymph nodes following load-induced OA and established the association of the presence and migration of T cells to the onset and progression of OA.

Methods: We used an in vivo model of OA to induce mechanical load-induced joint damage. After cyclic tibial compression of mice, we analyzed lymph nodes for T cells using flow cytometry and joint pathology using histology and microcomputed tomography. The role of T-cell migration and the presence of T-cell type was examined using T-cell receptor (TCR)α-/- mice and an immunomodulatory drug, Sphingosine-1-phosphate (S1P) receptor inhibitor-treated mice, respectively.

Results: We demonstrated a significant increase in T-cell populations in local lymph nodes in response to joint injury in 10, 16, and 26-week-old mice, and as a function of load duration, 1, 2, and 6 weeks. T-cell expression of inflammatory cytokine markers increased in the local lymph nodes and was associated with load-induced OA progression in the mouse knee. Joint loading in TCRα-/- mice reduced both cartilage degeneration (Osteoarthritis Research Society International (OARSI) scores: TCRα 0.568, 0.981-0.329 confidence interval (CI); wild type (WT) 1.328, 2.353-0.749 CI) and osteophyte formation. Inhibition of T-cell egress from lymph nodes attenuated load-induced cartilage degradation (OARSI scores: Fingolimod: 0.509, 1.821-0.142 CI; Saline 1.210, 1.932-0.758 CI) and decreased localization of T cells in the synovium.

Conclusions: These results establish the association of lymph node-resident T cells in joint damage and suggest that the S1P receptor modulators and T-cell immunotherapies could be used to treat OA.

Citing Articles

The role of Th/Treg immune cells in osteoarthritis.

Wen Z, Qiu L, Ye Z, Tan X, Xu X, Lu M Front Immunol. 2024; 15:1393418.

PMID: 39364408 PMC: 11446774. DOI: 10.3389/fimmu.2024.1393418.


PTH treatment before cyclic joint loading improves cartilage health and attenuates load-induced osteoarthritis development in mice.

Antoinette A, Ziemian S, Brown A, Hudson E, Chlebek C, Wright T Sci Adv. 2024; 10(16):eadk8402.

PMID: 38640238 PMC: 11029811. DOI: 10.1126/sciadv.adk8402.


Skeletal interoception in osteoarthritis.

Yang D, Xu J, Xu K, Xu P Bone Res. 2024; 12(1):22.

PMID: 38561376 PMC: 10985098. DOI: 10.1038/s41413-024-00328-6.

References
1.
Jacobs C, Vranceanu A, Thompson K, Lattermann C . Rapid Progression of Knee Pain and Osteoarthritis Biomarkers Greatest for Patients with Combined Obesity and Depression: Data from the Osteoarthritis Initiative. Cartilage. 2018; 11(1):38-46. PMC: 6921961. DOI: 10.1177/1947603518777577. View

2.
Silvestri T, Pulsatelli L, Dolzani P, Facchini A, Meliconi R . Elevated serum levels of soluble interleukin-4 receptor in osteoarthritis. Osteoarthritis Cartilage. 2006; 14(7):717-9. DOI: 10.1016/j.joca.2006.02.015. View

3.
Morris M, Gibb D, Picard F, Brinkmann V, Straume M, Ley K . Transient T cell accumulation in lymph nodes and sustained lymphopenia in mice treated with FTY720. Eur J Immunol. 2005; 35(12):3570-80. DOI: 10.1002/eji.200526218. View

4.
Dominguez-Villar M, Raddassi K, Danielsen A, Guarnaccia J, Hafler D . Fingolimod modulates T cell phenotype and regulatory T cell plasticity in vivo. J Autoimmun. 2018; 96:40-49. PMC: 7882197. DOI: 10.1016/j.jaut.2018.08.002. View

5.
de Lange-Brokaar B, Ioan-Facsinay A, van Osch G, Zuurmond A, Schoones J, Toes R . Synovial inflammation, immune cells and their cytokines in osteoarthritis: a review. Osteoarthritis Cartilage. 2012; 20(12):1484-99. DOI: 10.1016/j.joca.2012.08.027. View